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1INTRODUCTION
The term graft surveillance refers to periodic evaluation of the grafts by means
of tests that may involve special instrumentation, by which an abnormal result,
suggest, the presence of pathology .By graft surveillance, we can pick up failing grafts
and with corrective measures, patency rates can be improved.
The steady decline with time in the patency of vascular grafts mandates a
protocol of postoperative surveillance to identify grafts at risk of thrombosis since
bypass graft occlusion is associated with significantly morbidity and limb loss . The
correction of lesions before graft thrombosis can have a significant impact on long
term patency. It is particularly important for vein grafts because most will not
maintain patency after thrombectomy.
Careful postoperative evaluation of patients especially with infrainguinal
grafts over the past decade has clearly demonstrated that factors other than the skill of
the surgeon and the completion of satisfactory operative procedure will affect the
long term patency of vascular conduits.These factors vary depending on the interval
in the follow-up period.Factors adversely affecting 30 day patency are primarily
technical in nature and are related to surgical technique.Such factors are best
prevented and can often be identified by intraoperative evaluation.In the time period
between 1 month and 24 months fibrointimal hyperplasia in a variety of forms is the
primary cause of graft failure. Beyond 24 months the disease progression in both the
inflow and outflow vessels and the conduit degenerative changes results in graft
failure. The importance of graft surveillance has inspired to conduct this study in
order to clarify the natural history of graft failure.
2AIM
? To detect the hemodynamically failing and failed grafts regardless of
symptoms      during the follow up.
? To analyse the outcome of revision procedures.
? To study the influence of risk factor on graft survival.
3MATERIALS AND METHODS
Prospective study
Study period: May 2007 to April 2009
Patient selection
Randomly 98 grafts in 92 patients were enrolled in this study who underwent
bypass operation for critical lower limb ischemia and severe disabling claudication.
Inclusion criteria
All patients who underwent peripheral arterial bypass for critical limb
ischemia including major aortic surgeries
Fontaine classification of Chronic limb ischemia based on symptoms
I. Asymptomatic .( No hemodynamically significant occlusion)
II. Claudication
III. Ischemic rest pain
IV. Ischemic ulcer / Necrosis.
Exclusion criteria
? Acute limb ischemia.
? Upper limb ischemia
4? Visceral and cerebral ischemia.
? Immediately thrombosed grafts ( Within 24 hours)
ETIOLOGICAL FACTORS
Arterial disease of the lower limbs includes conditions such as inflammatory
arteritis,vasospastic disorders and medial calcification. However, by far the
commonest cause of peripheral arterial disease is Atherosclerosis consisting of slow
accumulation of lipids and fibrosis in the arterial intima.
All the patients were categorized according to the etiological factors as
? Atherosclerotic obliterans
? Thromboangitis obliterans :Fullfilling Shionoya's criteria
1. Less than 50 years age of onset
2. Smoking
3. Infrapopliteal lesion
4. Upper limb lesion
5. Phlebitis migrans and
6. Absence of  ASO risk factors
? Arteritis on the basis of raised CRP  and
? Hypercoagulable state ,based on positive test for cryoglobulin in
this study.
Cryoglobulins are immunoglobulin that precipitate  reversibly at low
temperature.
5MANAGEMENT OF CHRONIIC CRITICAL  LEG ISCHEMIA
1. Endovascular intervention: The optimum lesion for PTA(Percutaneous
transluminal angioplasty) are short stenosis or occlusions of the  iliac and the
proximal SFA with good run off.
2. Surgery : For long occlusion and infrainguinal lesion endovascular treatment is
more complex and if intervention is required then bypass surgery gives better results
3. Non-interventional management: In about 10% of patients ,it will be technically
impossible to revascularise th limb.Several pharmacological agents have been tried
and the most promising are prostanoids, particularly prostacyclin.Iloprost ,a stable
prostacyclin analogue , has reduced the amputation and death.In some patients the
limb survives ,but pain remains a problem.If simple analgesia is inadequate then
Lumbar sympathectomy either chemical or surgical may be helpful
In this study only patients who under went bypass surgery were enrolled.
INDICATION FOR BYPASS
? Severe disabling claudication: Patient develop severe claudication
symptoms after a few steps and walking is impossible even in the absence
of gangrene, ulceration or rest pain.
? Critical limb ischemia : The most European Consensus Document
defines CLI as persistent, recurring ischemic pain requiring opiate
analgesia for at leats 2 weeks and ankle systolic pressure lower than 50
6mmHg and or toe systolic pressure lower than 30 mmHg; or ulceration or
gangrene of the foot or toes  and ankle systolic pressure lower than 50
mmHg ( or absent pedal pulse in diabetics ).
Critical limb ischemia is often fatal if untreated, but even after arterial reconstruction
or amputation,40-75% of patients will die within 5 years of presentation mainly due to
cardiac problems.
LEVEL OF ANASTOMOSIS
All were categorized according to the level of occlusion and analysed for the
type of revascularization as follows
? Aorto iliac and Aortofemoral
? Iliofemoral
? Femoro – Femoral crossover
? Femoro –Popliteal
? Distal bypass
While performing distal bypasses we optimize the mechanical factors in distal
anastomosis in order to reduce the compliance mismatch and to reduce shear stress
by creating anastomotic vein cuff or vein patch (Millers cuff,Lintons patch,Taylors
patch and St Marys Boot ) in case of prosthetic graft placement .Also we  use topical
papavarine and intraoperative Dextran infusion 15 ml/hour, continued in
postoperative period  for 48 hours if cardiac function is good
7NATURE OF GRAFTS STUDIED.
All patients were separated according to the type of conduit used for bypass,
from the data during hospital stay and for few patients from the discharge summary
during the follow up into as
? Autogenous vein and
? Expanded PTFE.
GAUGING THE CLINICAL CHANGE AFTER BYPASS
Following revascularization  a sustained rise of >0.15 of ABI was taken to
indicate a Successfulbypass ( Normal ABI is > 0.97) and the clinical change is
gauged after revascularization as   follows.
Gauging clinical
change after
revascularizations + 3
Markedly improved
No ischemic symptoms
Foot lesions healed
ABI normalized – increased to more than 0.90
+2 Moderately improved
No foot lesion but still symptomatic with exercise
ABI not normalized but increased by >0.10
+1 Minimally improved
Greater than 0.10 increase in ABI but no categorical
improvement
No change No categorical shift and less than 0.10 changes inABI
- 1 Mildly worse
ABI decreased more than 0.10
-2 Moderately worse
One category worse or unexpected minor amputation
-3 Markedly worse
More than one category worse or unexpected major
amputation
8Limb salvage is defined as freedom from major amputation.
Minor amputation were defined as those result in a foot that could still be used
for  ambulation.
FOLLOW UP PERIOD
The initial evaluation of the graft starts prior to discharge or within one month
after  implantation,followed by on 3 months,6 months ,every 6 months for 2 years if
above three evaluation are normal .After 2 years annual evaluation for life.
All the patients were recommended aspirin, or clopidogrel and, statin in ASO
groups, postoperatively to decrease graft occlusion as well as for its cardio protective
effects  and  in  high  risk   group,  long  term  anticoagulation  (   Tab  .Acitrom)  was
advised.
METHODS OF SCREENING
At each visit grafts are screened by
? Clinical examination : Pulse palpation and auscultation for bruit
? ABI. Measurement using hand held continous wave Doppler
ABI is   calculated by measuring highest systolic ankle pressure divided by the
brachial systolic  pressure .Brachial pressure is taken as standardization because it
corresponds well with aortic and femoral pressure. Diastolic pressure does not fall
until the stenosis is quite severe and hence systolic pressure is sensitive.
9? Duplex scanning – Combination of B-Mode real-time anatomic
imaging  and Doppler spectral wave analysis with measurement of
flow and velocity.
? Angiogram to delineate the lesion and to planning the revision
procedure
Graft lesions were identified by recurrence of ischemia  ,change in findings at
clinical  examination  or with   routine duplex scanning. Following the clinical
examination and objective evidence of occlusion by duplex scan ,symptomatic
patients were subjected for Angiogram and revision procedures and the outcome were
assessed in terms of primary patency,assisted primary patency ,secondary patency
,limb salvage rate and patient survival rate.
GRAFT PATENCY
Primary patency : Patency is uninterrupted ie No interval procedure
Assisted primary patency: Primary patency is preserved after intervention
of failing graft ie intervening on a patent graft such as angioplasty of stenosed but
patent graft.
Secondary patency :Patency is restored after occlusion by any of the
following procedures
? Thrombectomy using fogarty and  adherent clot catheter
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? Thrombolysis using systemic or regional injection
streptokinase.(Contraindicated in early postoperative period (14 days),
however intra graft injection to clear residual thrombus in distal arterial
tree can be used) .Streptokinase therapy is monitored by serum
fibrinogen and the therapy discontinued if fibrinogen level falls below
100 mg.
? Transluminal angioplasty for focal stenosis less than 1.5 cm (Our
experience is limited due to lack of infrastructure )
? Patch plasty: Short focal stenosis (<4cm)
? Interposistion graft :Long stenosis >4cm
? Jump graft : long segment stenosis that approached the anastomosis
? Transposition graft :connecting the bypass to different vessel target
? Balloon angioplasty : focal lesion <1.5cm with segments of normal
caliber vein proximal and distal.
? New graft: For diffuse intimal hyperplasia with narrowed caliber
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DUPLEX SCANNING
The Duplex scan is highly sensitive and specific for identifying lesion that
threaten the graft patency. Duplex  scan  identifies failing graft which is defined as
hemodynamic disturbances without thrombosis. Color flow image rapidly identifies
the region with high velocity or disturbed flow.
The criteria for graft lesion by Duplex scan  depends on the velocity ratio
should be recorded at site were velocities are abnormally elevated
Many defects detected during early postoperative  period  is due to residual
defect caused by technical imperfection or residual disease . The residual defect have
a velocity spectra of a moderate stenosis(30-60% diameter reduction) and thus are not
associated with impairment of blood flow or perfusion pressure .It does appear that
such residual defect in an arterial reconstruction increase the likelihood of clinical
feature ,usually as a result of progressive myointima hyperplasia.
Important issues regarding graft surveillance include when the duplex
surveillance begin, how long it should be continued and at  what frequency to be
performed. The first duplex scan should be performed at operation theatre if feasible,
if not prior to discharge from hospital.The predischarge duplex examination permits
identification of bypass which are prone to progress ,which if it occurs and is
corrected in timely fashion dramatically reduce the incidence of thrombosis within
first year after surgery.Graft sueveillance should be indefinite with majority of
patients requiring an annual evaluation after first year
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It helps to screen the whole graft where the following sites can be sampled
1. Proximal anastomosis
2. Proximal  graft
3. Mid graft
4. Distal graft and
5. Distal anastomosis
Duplex criteria for normal flow in graft is PSV  less than 125cm/sec &
velocity ratio of 1:1.4
When flow disturbance is identified by duplex scan it is graded for severity by
measurement of
? Peak systolic Velocity,
? Graft Flow Velocity
Highest PSV with stenosis (V2)
? Velocity ratio :
Normal proximal PSV( V1)
? And when coupled with ABI can be used to categorise lesions as low
risk ,intermediate risk, or high risk for graft thrombosis as follows .
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THROMBOTIC RISK CATEGORY
Risk level High velocity
criteria And
Low velocity
criteria
And ABI
reduction
Highest PSV >300 or
Vr >3.5 or
EDV >100
And GFV <45 Or >0.15
High PSV >300 or
Vr >3.5
And GFV >45 And <0.15
Intermediate PSV 180-300 or
Vr >2
And GFV>45 And <0.15
Low PSV <180 And GFv>45 And >0.15
CALCULATING VELOCITY RATIO:    V2/ V1
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The diameter of the vein graft recorded, as large diameter ( normal 3-6mm)
will tend to have lower velocities. A graft that has consistently been a low flow graft
is less worrisome than one that  shows a serial change and develops a low flow
velocity. A graft that has consistently low flow velocities may simply have
? .Large graft diameter
? .Low cardiac output or both.
When a graft develops a low flow state, attention should be directed to
possible causes
? Loss of inflow
? Outflow impediment
? Critical graft stenosis creating a impediment of flow.
The shape of Doppler waveform is also important. Early in the postoperative
period ,grafts have a continous antegrade flow during the cardiac cycle. This is
thought to be secondary to the chronic vasodilatation caused by the baseline
peripheral arterial lesions that have bypassed. As vascular tone is is regained over
time the waveform becomes triphasic .Conversion from a triphasic to a monophasic
waveform with decreased PSV is suggestive of a remote occlusive lesion. A
preocclusive staccato signal portends a poor prognosis and is indicative of high grade
stenosis in the distal graft.
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The most common lesion  that appears or progress  after one month of surgery
is  by  intimal  hyperplasia  that  forms  at  a  valve  site,  at  anastomosis,  venovenostomy
site  or  within  the  graft  body.  Intimal  hyperplasia;  universal  response  of  vessel  to
injury,describes a chronic structural change in denuded arteries,arterialized vein and
prosthetic grafts.
Lesion appears during late postoperative  period ( > 2 years ) often are disease
progression of native arteries and occur with vein graft proper (ASO) or in the inflow
or outflow arteries .
EXPECTED RANGE OF NORMAL VELOCITIES IN AORTA AND LOWER
LIMB ARTERIES
Vessel PSV EDV
Aorta 60-110 cm/sec
Iliac 119.3 +/- 21.7 16.4 +/- 7.5 cm/sec
CFA 114.1+/- 24.9 14.5 +/- 8.3
SFA prox 90.8 +/- 13.6 14.5+/-7.2
SFA mid 93.6 +/-14.1 14.6+/-6.7
SFA dis 68.8+/-13.5 9.8+/-6.0
The duplex finding in stenotic areas as follows
Stenosis: Flow reversal disappears
Reduce peripheral resistance due to relative ischemia
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Damping pressure wave
Proximal to stenosis: High forward flow
Stenosis manifest as spectral broadening
Monophasic flow  means  flow  always  forward  due  to  stenosis  and  low
peripheral resistance(capiilaries open which is normal only after exercise and not in
stenosis / obstruction)
Dampened flow: Distal to severe arterial obstruction due to slowed systolic
acceleration & increased diastolic flow.
End diastolic velocity :  Highest end diastolic velocity .It will be normal till 50% DR
(diameter reduction ).It will be elevated in 50-70 % DR to  >100cm/s
STENOSIS RANGE AND EXPECTED VELOCITY CHANGES
% stenosis Peak velocity Vr waveform
Normal <150 <1.5:1 Triphasic
30-49 % 150-200 1.5:1-2:1 Triphasic spectral broadening
50-75 % 200-400 2:1-4:1 Monophasic spectral broadening
>75% >400 >4:1 Monophasic spectral broadening
Occlusion No flow No signal
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Grafts with low risk and intermediate risk are followed for progression
.Intervention of the failing graft is recommended when PSV is >300 cm/sec and PSV
ratio is more than 3.4.  and for uniform low flow graft suggesting either inflow or
outflow disease outside the graft .Angiogram  was taken in all patients planned to
revise in order to delineate the lesion and to plan the treatment .
Idu etal reported all infrainguinal vein grafts with 70% diameter reduction
eventually occluded, compared to 10% of grafts, with similar lesion which were
revised.
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STATISTICAL ANALYSIS
This study was statistically analysed by the Chi-square test to
compare the
? Rate of graft lesion to that of etiology
? Rate of graft abnormality with the level of bypass
? Risk factors to that of graft patency
? Role of anticoagulation in graft patency
? Relationship of Etiology to that of outcome
? Influence of risk factors to the outcome
? Relationship of the graft nature to the patency
? Relationship of the type of surgery to the outcome
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OBSERVATION & RESULTS
From May 2007 to April 2009 review of  a prospectively collected data was
performed of 100 patients who underwent bypass for lower limb ischemia due to
various etiology was  randomly selected and enrolled in this Study. Majority of them
had critical limb ischemia as the indication of surgery. Two patients were excluded
from the study due to poor follow up compliance and finally there were 92 patients in
the study, 85 were males (92%) and seven females ( 8%).
Sex Distribution
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39.2 39.5 36
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Age Distribution
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A total of 92 patients who underwent peripheral arterial bypass procedures
whose data were collected.  A total of 98 bypass grafts were enrolled for the study
including the sequential bypasses(n=6).
The major risk factors were of smoking in 77%, diabetes mellitus,
hypertension and coronary artery disease association in more than 40% of patients.
Two female patients had history of carcinoma cervix with pelvic irradiation which
accelerates the atherosclerosis
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RISK FACTORS AND COMORBIDITIES
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Regarding the etiology majority of the patients were having atherosclerotic
risk and with mean age of 56.5years. Thromboangitis obliterans fulfilling Shionoya’s
criteria stood second in the study and only one had evidence of hypercoagulability
cryoglobulin positive.
22
63%
30%
6% 1%
0%
10%
20%
30%
40%
50%
60%
70%
AS
O
TA
O
Ar
ter
itis
Hy
pe
rco
ag
lab
le
Etiology
Series1
Out of 98 grafts studied, 48 were of prosthetic grafts and 50(including 6
sequential infrainguinal vein bypass) were of autogenous veins used as a conduit for
the bypasses. Only two prosthetic grafts were used for infrainguinal above knee
femoropopliteal bypass due to lack of vein conduit and all other grafts wee used for
proximal  aortic and iliac bypasses.
All patients were on life long antiplatelet drugs and or anticoagulation in
selected group of patients (e.g., patient with hypercoagulability, grafts at high risk of
thrombosis such as single vessel run off and in arteritis patients). Statins were given in
all atherosclerotic patients and were continued postoperatively.
Angiograms were done in all failing and thrombosed grafts that required
intervention. There findings were well correlated with that of the Duplex scan
(100%).
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TYPE OF SURGICAL PROCEDURES
Aortobifemoral - 9 (9.1%)
Aortounifemoral - 15 ( 15 %)
Aortobiiliac - 5 (5.1%)
Iliacofemoral - 11 (11.2%)
Iliacoprofunda - 5 (5.1%)
Femoro-femorol crossover grafting - 1( 1%)
Femoropopliteal Above knee - 8 (8.1%)
Femoroplpliteal Below knee - 13 (13%)
PT bypass - 15 (15%)
AT bypass - 5 (5.1%)
Peroneal bypass - 5(5.1%)
Sequential - 6(6%)
Total - 98 ( grafts)
TYPES OF SURGERY
9.10%
15.00%
5.10%
11.20%
5.10%
1%
8.10%
13%
15.00%
5.10% 5.10%
6%
0.00%
2.00%
4.00%
6.00%
8.00%
10.00%
12.00%
14.00%
16.00%
Ao
rto
bif
em
or
al
Ao
rto
un
ife
mo
ral
Ao
rto
bii
lia
c
Ilia
co
fem
ora
l
Ilia
co
pro
fun
da
Fe
mo
ro-
fem
or
ol 
cro
ss
ov
er
gr
aft
ing
Fe
mo
rop
op
lite
al 
Ab
ov
e k
ne
e
Fe
mo
rop
lpl
ite
al 
Be
low
 kn
ee
PT
 by
pa
ss
AT
 by
pa
ss
Pe
ron
ea
l b
yp
as
s
Se
qu
en
tia
l
Series1
24
SEQUENTIAL BYPASS IN MULTISEGMENTAL OCCLUSION N=6   (6% )
Aortobifemoral to proximal popliteal - 2
Aortounifemoral to proximal popliteal - 1
Aortoprofunda to distal popliteal - 1
Ilioprofunda to proximal ppoliteal - 1
Ilioprofunda to posterior tibial artery - 1
Total - 6
SEQUENTIAL BYPASS  IN MULTISEGMENTAL
OCCLUSION
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GRAFT NATURE:
Out of 98 grafts surveyed, autogenous vein were used in 50 bypasses
(Infrainguinal – 44 & sequential infraguinal - 6) and prosthetic grafts in 48
patients(Aortic and iliac – 45, Infrainguinal – 2, Fem Fem crossover – 1).
GRAFT NATURE
47
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PRIMARY PATENCY RATE AT THE END OF THE STUDY
The primary patency in our study is 61.2 % (n=60 / 98) where  Duplex scan
showed normal patent graft during the first visit. -
Bypass wise
Aorto-Bifemoral - 55.5% ( 5 / 9)
Aorto –Biiliac - 60% (3 /5)
Aortounifemoral - 53% (8/15)
Iliaco-femoral - 75% (12/16)
Femoropoplital - 52.3% (11/21)
Distal Bypass - 64% (16/25)
Sequential Bypass - 83.3% (5 /6)
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FAILING GRAFTS ACCORDING TO THE PERIODICITY
Detected during follow up, n = 21 (by duplex scan) and graded as follows
Risk PTFE Graft (N) Vein Graft(N) Number %
Low 2 1 3 14.2%
Intermediate 2 1 3 14.2%
High - 5 5 23.8%
Highest 4 6 10 47.6%
Total 8 13 21
Out of the 21 failing grafts, seven( 33.3%) were intervened  during the follow
up period, out of which only two grafts could be salvaged, two had subsequently
occluded following surgery and rest of the three patients expired. Out of the two
occluded grafts following revision procedures one required major amputation and one
patient was managed conservatively.
So, the overall assisted primary patency rate in this study was increased
to 63.26% after salvaging the failing grafts.
Rest of the 14 grafts in the failing group were observed, out of which only one
graft was occluded subsequently within three months period.
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OCCLUDED GRAFTS IN THE STUDY
In our study, 17 out of 98 grafts(17.3%)were occluded in the follow up period.
Revision procedures were performed in all symptomatic patients(n=8) and primary
amputation were performed in four patients who had non salvageable foot and rest of
the patients were observed. Only three grafts could be salvaged in this group
(Aortounifemoral  bypass -1, Iliofemoral bypass -1 and Femoropopliteal bypass-1),
two required subsequent secondary amputation two were reoccluded and patient
expired due to sepsis following graft infection.
29
INCIDENCE OF GRAFT OCCLUSION AT THE END OF THE STUDY
Total - 17/98 (17.3%)
1. Early thrombosis - 6    (35%)
(Iliofemoral – 1, Fempop – 1, PT bypass – 2, AT bypass – 1, Peroneal – 1)
2. Midterm thrombosis - 8 (47%)
(Aortobifemoral – 1, Aortounifemoral – 3, Iliofemoral – 2, Fem- Fem
crossover – 1, Peroneal – 1)
3. Late thrombosis - 3    (17.6%)
(AortobiIliac – 1, Femeropopliteal – 1, PT bypass – 1
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The above table shows the number of grafts occluded during the follow up
according the duration. Majority (55%) of the grafts occluded after one month to two
years of surgery.
INCIDENCE OF GRAFT THROMBOSIS IN PROSTHETIC GROUP
Early thrombosis - 1
Mid term thrombosis - 7
Late thrombosis - 1
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The pie diagram showing the incidence of graft thrombosis is higher in the
prosthetic group compared to the vein group (53% Vs 47%)
Majority (70%) of the failing grafts were managed conservatively due to want
of availability of endovascular interventions and many of them were asymptomatics
with good ABI and they are on close follow up. They will be considered for
intervention as and when required.
The secondary patency rate in the study was 17.6%(n=3, out of 17 grafts)
And  the  overall  graft  patency  in  the  study including assisted primary and
secondary were 66.3%.( n=65 ).
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The overall amputation in our study was 7.7% (n=7), out of which six were in
the occluded group, one was in the failing group. The mortality rate in this study was
4.3%.
33
The limb salvage rate in our study was relatively higher (n=92, 92.3%)
compared to the graft patency (67.3%) including the patients those were observed.
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Rate of  graft lesion to that of etiology
NORMAL OCCLUSION FAILING TOTAL
ASO 42 7 12 61
TAO 15 8 7 30
ARTERITIS 3 2 1 6
HYPERCCOAGULABLE 1 1
TOTAL 60 17 21 98
P=0.185, not significant
TAO and arteritis had increased risk of graft occlusion during the follow up.
Only 11% of the grafts were occluded in atherosclerotic patients. This difference is
not significant(p = 0.185)
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Rate of graft abnormality with the level of bypass
NORMAL OCCLUSION FAILING
AORTOILIAC 28 8 9
FEMPOP 16 4 7
DISTAL 16 5 5
TOTAL 60 17 21
P=O.96 ,not significant
The occurrence of graft stenosis or occlusion is more common in patients who
underwent infrainguinal or infragenicular bypasses. This could be due to the increased
resistance and low flow state in peripheral arteries compared to that of central arteries.
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Risk factors to that of graft patency
NORMAL OCCLUSION FAILING
SINGLE 24 15 12
DOUBLE 32 2 8
MULTIPLE 4 0 1
TOTAL 60 17 21
P=O.012
The above table shows that there is no statistically significant difference in the
influence of risk factors to the graft patency. In our study even patients those who had
mulltiple risk factors had primary graft patency of 80%.
37
Role of anticoagulation in graft patency
POSTOP ORAL
ANTICOAGULATION
NORMAL OCCLUSION FAILING
YES 15 10 15
NO 45 7 6
TOTAL 60 17 21
P=0.001
The role of anticoagulation in overall graft patency were compared. 77% of
patients who did not receive anticoagulation had normal patent graft when compared
to only 37% of patients who received anticoagulation had normal graft. This
difference is not significant, probably many factors like etiology, level of occlusion,
etc., influence the occurrence of graft lesions.
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Relationship of Etiology to that of outcome
LIMB
SALVAGE
AMPUTATION EXPIRED
ASO 56 2 3
TAO 25 4 1
ARTE 5 1 0
HYPERCOAGULABLE 1 0 0
TOTAL 87 7 4
P=0.62, not significant
Although, majority of the patients were expired in atherosclerosis group
compared to that of TAO where the rate of amputation was high, this difference is not
statistically significant.
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Influence of risk factors to the outcome
LIMB SALVAGE AMPUTATION EXPIRED
Single 44 6 1
Double 38 1 3
Multiple 5 0 0
TOTAL 87 7 4
P=0.08
As the number of risk factors increases the rate of mortality increases . This
value is not statistically significant because those who had three or multiple risk
factors did not have any mortality in our study. And at the same time there is no
difference in the influence of risk factors on graft patency.
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Relationship of the graft nature to the patency
NORMAL OCCLUSION FAILING
PTFE 29 9 10
VEIN 31 8 11
TOTAL 60 17 21
P=0.93, not significant.
In  our  study  the  rate  of  graft stenosis is more common in venous group
compared to that prosthetic group where occlusion is more common. This is not
statistically significant.
41
Relationship of the type of surgery to the outcome
LIMB SALVAGE AMPUTATION EXPIRED
AORTOILIAC 41 1 3
FEMPOP 22 4 1
DISTAL BYPASS 24 2 0
TOTAL 87 7 4
P=0.21 Although this data is not statistically significant, aortic surgeries had
higher mortality when compared to infrainguinal surgeries. The rate of amputation
was more in infrainguinal bypass group(P=0.21)
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DISCUSSION
Despite advances in surgical techniques peripheral arterial bypass graft failure
occurs and remains a major problem for vascular surgeon and rescue of thrombosed
graft especially  vein graft with thrombectomy or thrombolysis usually do not result in
restoration of durable patency. Furthermore replacement of a failed bypass graft with
a new bypass graft poses a variety of challenge to the surgeon, including scarring,
shortage of autogenous vein and increased patient morbidity.Thus the result of repeat
bypass surgery after failed bypass are inferior to those of primary bypass surgery. It is
therefore imperative to maintain the patency of peripheral bypass grafts.
As arterial bypass surgeries are palliative procedures perse not curing, the
disease progression, highlighting the need for graft surveillance. Although clinical
examination, ankle brachial index during the postoperative period help in detecting
the hemodynamically significant lesion, color Doppler has shown a major difference
in detecting the early failing grafts even in asymptomatic patients.
From May 2007 to April 2009 review of  a prospectively collected data was
performed of 98 grafts in 92 patients who underwent bypass for lower limb ischemia
due to various etiology, was randomly selected and enrolled in this study. The
surgeries were performed by different surgeons in our department.
In our study, duplex scan had 100%  sensitivity in detecting the graft lesion as
compared to that of the study done by Calligaro (Reference : Practical Vascular
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Surgery, James S.T.) and colleagues where they had shown only 81% sensitivity
when compared with clinical examination and ABI.
According to Louis (Literature - From the Society of Vascular Surgery, June
2004),  study the incidence of mid term graft failure was 20 to 50% which is
comparable to our study where the mid term failure was upto 55% for infrainguinal
vein bypass.
Wolfe et al (Vascular and Endovascular Intervention and Surgery update
1996,  Dr. Pinjala Ramakrishna, M.S. FRCS) showed that 50 to 80% of lesions may
be missed if we depend on ABI, in our study also the reliability of  ABI in identifying
the failing graft was about 58 % which is inferior to that of duplex scan comparable
with that of Calligro et al study.
The positive predictive value for Duplex scan in defining normal patent graft
is 100%. Even though duplex identifies critical lesion in vein grafts, almost all of
them resulted in thrombosis at  the time of intervention and all  of them needed a new
conduit.
The incidence of failing graft in infrainguinal bypass is more for PTFE group
(50%) than vein group which is of 18 % when compared to other studies by Michael
Belkin etal where they reported failure rate of 28.6% when compared to vein groups
of 13.6% failure rate. (Journal of Vascular Surgery, February 1995)
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Even though our study is of two year period, the primary graft patency was
better in atherosclerosis(70%) than that of TAO(25%) and arteritis(5%). The rate of
primary patency in TAO was 49%  in a study BY Sasajima and colleagues (Manual
of vascular disease by Sanjay Rajagopalan MD, Edition-2005)
In this study, the infection rate in prosthetics graft was 2 % comparable to the
graft infection of Aortofemoral bypass 1 % study  by Moore WS, cole CW( Infection
in prosthetic vascular grafts, A comprehensive review 1991 )
The incidence of Anastomotic femoral aneurysm is 2.1 % (Anastomotic
aneurysm incidence2.4 % in femoral arteries in literature Goldstone J .-complications
in vascular surgery 1991) The factors precipitating pseudoaneurysm are suture
failure,graft infection,graft dilatation ,End-Side anastomosis and arterial degeneration.
In our study we have observed that diabetic mellitus does not adversely affect
graft patency and in one patient, who is a diabetic underwent  Aortouni-iliac bypass
using PTFE graft showed 8 years of primary patency rate on angioevaluation for
peripheral arterial occlusive disease in opposite leg. (Stated in journals -Diabetes
does not adversely affect the patency rate of a graft in chapter, Influence of diabetes
& other factors on graft patency (journal of vas surgery august 2007).
The overall patency rate for Aortic bypass in this study is 65.5% when
compared to other series (Aorto femoral bypass Patency 85 – 90 % - Brewster
DC,Cooke JC –Long term results in vascular surgery -1993 ) which can be explained
,by the lesser diameter of arteries when compared to western population and the
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combination of early inflammatory arteritis and subsequent atherosclerotic pathology
in the evolution of peripheral arterial occlusion.
The overall patency rate for Femoropopliteal bypass using vein in this study
is 52.3% when compared to other series ( Patency rate for Femeropopliteal bypass
with  vein  is  84  % both  for  proximal and distal bypass- Review by Dalman - 2000 )
which can be explained by the etiological factors ( 20% of the patients were of TAO
and Arteritis n=4 who had elevated CRP and where we were forced to do bypass
under steroid cover due immediate threat to limb ) and since our institution is  a
teaching center  , the residents tend to get more chances of doing bypasses  and
hence in the learning period technical problems are more.
The  primary  patency rate for PTFE Above knee  Femoropopliteal bypass in
this study is 50% ( compared to  79 % in the western series – Review by Dalman -
2000 )This can be explained due to low sample in this study since, we mostly prefer
Autogenous vein for all infrainguinal Bypass.
The overall patency rate for distal bypass in this study is 64% (n=16) when
compared to 77 % reported in literature (Review of results in infrainguinal bypass
Dalman - 2000)
Most of the vein graft failed due to intrinsic graft lesion n=9
(54%) which is comparable with study done by Donaldson, Mills coworkers
Rutherford (60 % of vein graft failed due to focal intrinsic lesion)
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In this study 18 % of vein group failed at the end of this study when compared
to 15-20 % in study by Donaldson, Mills coworker)
In  this  study  83  %  of  vein  group   developed  lesion  and  thrombosed   by  one
year when compared to ( Mills description  80 % lesion in 1 year )
In this study we used a PTFE – Vein composite graft (n=2) in Redo surgery
for infrapopliteal bypass n=1 and distal bypass n=1 .The outcome are early graft
thrombosis 100% and amputation  rate is 50% when compared to literature which
showed 49.4 % Graft thrombosis and 40% amputation rate- P.A.STONEBRIDGE
etal British journal of surgery February 2000)
Distal bypass using PTFE and a distal anastomotic interposition vein cuff is
to avoid compliance mismatch between the prosthetic graft and native artery.The
protective effect may be humoral in origin ,possibly by reducing the activation of
growth factors by the presence of an autogenous endothelium buffer zone.
(P.A.STONEBRIDGE etal British journal of surgery February 2000)
The rate of limb salvage in patients with failed grafts was 65% when
compared to literature (only 50% at 2 yrs after failure. - Midwestern vascular
surgical society Chicago September 2003)
In our study 20 %( n=1) of revised grafts developed subsequent distal  graft
critical stenosis (Arteritis with elevated CRP due to steroid default ) and additional
revisional procedure in the form of PTFE  patch plasty and graft salvaged . This
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reflects the ongoing disease activity the cause for recurrent graft failure which needs.
Vigilant ongoing surveillance , for revised grafts because 30.9% of revised grafts will
develop additional lesions that will, require repair as reported in literature.( Society of
vascular surgery. Anaheim, California,J une 2004)
In our study PTFE grafts to Femoropopliteal bypass also benefited from
surveillance by identification of anastomotic stenosis n=1/2(50%) in contradictory to
report in literature - KEITH D .CALLIGARO Annals of vas surgery –Aug 2001-
Results support the graft surveillance protocol for femorotibial  but not
femoropopliteal ,prosthetic grafts
In our study duplex report correlated 100 % with report of CT angiogram and
conventional angiogram similar  to  other  study CT Angiogram-Comparison with
duplex and DSA( Jurgen K Willmann,MD etall Institution of diagnostic radiology
and cardio vascular surgery ,Zurich, Switzerland Sep 2002 -No statistical difference
in sensitivity or specificity between CTA and duplex in detection of graft lesion)
We start patients on long term oral anticoagulants who were asymptomatic
with duplex report of Low flow graft to prevent graft occlusion.the benefits have been
studied by  R. Brumberg etal reporting 89% patency in patients on warfarin for low
flow graft when compared to 55% who were subtherapeutic or not anticoagulated.(
Annals of Vascular surgery 2007- Therapeutic warfarin augment the patency of low
flow graft )
48
In our study we have observed  less graft lesion in infrainguinal bypass
vein graft  who were on statins (ASO groups 47% n=9) than when  compared  to
patients not on statin ( TAO and Arteritis groups 53% n=10) as reported in literature .
Statin therapy is associated with improved patency in infrainguinal vein graft
by preventing stenosis and occlusion . (Thomas a abbruzzese New England Society
for vascular Surgery 2004 -HMGA CO A reductase inhibitor( 3-hydroxy 3-methyl
coenzymeA inhibitors) because of Atheroprotective , Antithrombotic &
Antiinflammatory (independent effect) apart from lipid lowering effect. Control
group 2 years Revised graft patency rate 83% and Statin group 94 % .Secondary
patency rate in control group 92% and Statin group 97 %)
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CONCLUSION
? Graft surveillance programme should be mandatory in all peripheral arterial
bypass grafts. Limb salvage rate may be increased by doing intraoperative
duplex scan which detects the failing grafts in the operation theatre itself,
thereby avoiding the need for second anaesthesia and surgery.
? The usefulness of duplex scan in improving the assisted primary patency
which has been proved by many studies mandates the need for graft
surveillance.
? In view of its non invasiveness, Duplex scan plays a major role in detecting
the hemodynamically failing grafts before the patient becomes symptomatic.
The sensitivity and specificity of it is comparable with that of the invasive
angiogram, hence avoiding the need for it.
? The dependability of Ankle brachial index increases when it is coupled with
clinical examination and color Doppler ultrasound than independently.
? One should be aggressive in salvaging the autogenous vein grafts as the
intraluminal thrombus  fixed to the intimal layer disrupts the endothelial
function whereas thrombosis of prosthetic grafts is not as detrimental as vein
occlusion which may be removed by thrombolysis or thrombectomy.
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? Though the presence of risk factors increases the cardiovascular mortality in
these patients during the perioperative period, it does not affect the overall
graft patency.
? In occluded grafts, even though revision procedures are time consuming than
simple thrombectomy one should not hesitant to do it to improve the
secondary patency.
? No single approach is appropriate for all patients and thus the interventions
must be tailored to the individual.
? Long term anticoagulation with INR monitoring should be considered for
selected group of patients with high risk of graft thrombosis or in those who
required revision procedures.
? Vigilant graft surveillance is  essential  throughout  the  life  to identify the late
lesion and also the future lesion in revised grafts.
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